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Abstract
Background: Children with cardiac defects need many hospitalizations and repetitive antibiotic therapies, with an
increasing risk of colonization with multidrug-resistant bacteria (MDRB) such as extended-spectrum β-lactamase-
producing Enterobacteriaceae (ESBL-E) Post-operative infections with these bacteria in paediatric cardiac surgery are
life threatening. This article aims to study the prevalence of ESBL colonization among paediatric cardiac surgery
patients, and to compare occurrence of post-operative infections with and without ESBL colonization. We also aim
to study the correlation between the onset of postoperative infection and other parameters such as age, length of
stay and preoperative antibiotic therapy.
Methods: A retrospective cohort study included paediatric cardiac surgery patients in Cheikh Zaid hospital in Rabat,
Morocco, between the 1st of January 2011 and 31 December 2014. A screening for ESBL colonization was requested for
children who had a risk factor (previous hospitalization and/or taking antibiotics) at admission. Swabs were collected from
three sites (throat, nose and anus). Two groups were compared – patients colonized and not colonized with ESBLs.
Statistical analysis was performed using R software.
Results: ESBL colonization screening was performed in 111 patients. Positive colonization was detected in 17 cases (15%).
Klebsiella pneumoniae (KP): 9 (53%) was the most frequently isolated species. Among the 17 patients, 23.5% (4/17)
developed a postoperative infection due to ESBLs versus only one patient without colonization (1%).
There was a statically significant difference in terms of occurrence of postoperative infection between the two
groups (p = 0.001). Relative risk of developing a postoperative infection with positive colonization was 22
(95% CI, 8.37–58.5).
Conclusions: The analysis of colonization with multidrug-resistant bacteria and the prevention of nosocomial
infections appear to be important challenges for paediatric cardiac surgery. Systematic screening of ESBL
colonization for cardiac surgery could have a significant contribution, on one hand to guide prophylactic antibiotic
therapy of patients, and on the other, to prevent spread of those infections.
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Background
The prevalence of ESBL-E carriage has changed signifi-
cantly over time. However, this evolution varied by geo-
graphical region: it was more prevalent in the Western
Pacific, Eastern Mediterranean, and Southeast Asia re-
gions. In contrast, rates reported in Europe never
exceeded 10% [1].
ESBL colonization among hospitalized patients world-
wide is highly assessed. For instance, in 2003, the rate
was about 11.8% in Spain [2], 16% in Lebanon [3] and
26% in Saudi Arabia [4]. Nevertheless, a prospective
study performed in Turkey showed that 18.5% of chil-
dren carried ESBL-producing K. Pneumonia. The impact
rate of the nosocomial infections due to this strain is
about 1.6% among hospitalized children [5].
One of the major causes of the increase in the preva-
lence of colonization by multidrug-resistant germs is the
misuse of antibiotics. Antibiotic use creates a selective
pressure on host bacteria in the large bowel, leading to
the emergence of antimicrobial-resistant organisms,
which in turn causes an increase in the number of
carriers harbouring resistant bacteria and enhances the
opportunity for these bacteria to cause infections [6].
In cardiac surgery, factors such as extracorporeal cir-
culation, hypothermia, peripheral tissue hypo-perfusion
and invasive medical devices like implantable materials
may constitute major risks for increased perioperative
infection and complication rates [7].
Whereas these infections are potentially lethal as well
as costly, they remain in close relationship to catheter-
related bloodstream infections in intensive care units
(ICUs), which are a certain kind of medical practice
[8, 9]. For instance, each year in the United States,
central venous catheters are responsible for approximately
80,000 catheter-related bloodstream infections and, as a
result, up to 28,000 deaths among ICU patients [10].
ESBL-producing organisms are responsible for a sig-
nificant proportion of infections in ICUs. Treatment of
these infections can place an added constraint on already
overburdened health systems in developing countries
[11]. Nosocomial infections attributable to these bacteria
have been known to cause high mortality [12]. Several
reports have addressed faecal colonization of these or-
ganisms during nosocomial infection outbreaks [13, 14].
Therefore, screening of ESBL colonization is very im-
portant in order to guide pre-operative prophylaxis and
appropriate empirical antibiotic therapy of infected pa-
tients. In addition, this screening is useful to prevent
nosocomial spread of these multi-drug resistant bacteria,
reducing morbidity and mortality rates.
However, to our knowledge, there are few studies
addressing the impact of carriage of ESBLs on the preva-
lence of postoperative infections in paediatric cardiac
surgery either in Morocco or elsewhere.
This article aims to estimate the prevalence of ESBL
colonization among children who underwent cardiac
surgery in our hospital from January 2011 through
December 2014. The primary objective of our study
was to identify whether colonization with ESBLs is a
risk factor for developing post-operative infections
with these bacteria.
The secondary objective was to study the association
between post-operative ESBL infection and parameters
like age of patient, duration of hospitalization and pre-
operative antibiotherapy.
Methods
To identify whether colonization with ESBLs is a risk
factor for developing post-operative infections with these
bacteria, a retrospective cohort study was conducted at
Cheikh Zaid hospital in Rabat, Morocco. The Cheikh
Zaid hospital is an international teaching establishment.
It contains 350 beds comprising various medical and
surgical specialties, a paediatric unit, a maternity unit
and three intensive care units with approximately
55,000 days of hospitalization and about 180 paediatric
cardiac surgeries per year. Cheikh Zaid hospital is a
reference centre for paediatric cardiac surgery at the na-
tional level.
Screening of ESBL colonization was performed based
on risk criteria at admission (previous hospitalization
and/or antibiotic therapy within 14 days before admis-
sion). Microbiological swabs were collected from the
throat, nose and anus. They were spread onto two
MacConkey Agar plates; one of the agars was supple-
mented with 1 μg/ml of cefotaxime and the other one
with 1 μg/ml of ceftazidime, and both were incubated at
35 °C for a minimum of 24 h [15]. Suspected ESBL col-
onies were confirmed with the disc diffusion method on
Mueller-Hinton Agar using cefotaxime, ceftazidime, cef-
podoxime and ceftriaxone with amoxicillin/clavulanic
acid as recommended by the European Committee on
Antimicrobial Susceptibility Testing (EUCAST). Growing
organisms were identified by using the API system
(bioMérieux, Lyon, France) [16].
Data concerning post-operative infections were col-
lected from laboratory information system and patient
records. Only ESBL post-operative infections were re-
ported in the present study.
Distribution of patients’ characteristics was reported
using mean and standard deviation (SD) for quantitative
variable, while qualitative data was reported using absolute
frequencies and percentages. In the end, two groups were
defined: ESBL colonized and non-colonized patients.
The prevalence of occurrence of ESBL post-operative
infection was calculated for both groups. To compare
qualitative variables, we used the Chi square test. When
the application conditions were not met, we used
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Fisher’s exact test. The variables associated with postop-
erative infection (age, length of hospitalization and pre-
operative antibiotherapy) were studied by univariate and
multivariate logistic regression. The p-value was consid-
ered significant at a level lower than 0.05. Statistical ana-
lysis was performed using the R software environment
and Statistical Package for the Social Sciences (SPSS)
version 13.0 software for Microsoft Windows XP.
Results
Screening for ESBL colonization was performed in 111
patients. The median age was 240 days (interquartile
range [IQR]: 120–420 days). ESBL colonized patients
represented 17/111 (15%) and non-colonized patients
represented 94/111 (85%). Isolated species were Klebsiella
pneumoniae: 9 (53%), Escherichia coli: 6 (35%) and Entero-
bacter cloacae: 2 (12%).
Among the 17 colonized patients, four (23.5%) devel-
oped a postoperative ESBL infection (Klebsiella pneumo-
niae: 2 (50%) and Escherichia coli: 2 (50%)). Among
non-colonized patients, one patient (1%) developed an
infection with ESBL (Enterobacter cloacae). The percent-
age of post-operative infection in colonized patients was
23.5% and it was 1% in patients who were non-
colonized. The relative risk of developing a postoperative
infection in colonized patients was 22 (95% CI, 8.37–
58.5). There is a significant difference in terms of
incidence of occurrence of ESBL postoperative infection
between the two groups (p = 0.001). Univariate logistic
regression showed that post-operative infection was not
influenced by overall duration of hospitalization
(p = 0.687), age (p = 0.753) or pre-operative antibiother-
apy (p = 0.818). On the other hand, univariate linear re-
gression showed that post-operative infection was
influenced by carriage of ESBLs (p = 0.004). We did not
perform multivariate analysis because only one param-
eter (ESBL colonization) was significant in the univariate
analysis.
The study design and results are detailed in Fig. 1 and
Tables 1 and 2.
Discussion
According to our knowledge, few studies have focused
on post-operative infections caused by ESBLs in paediat-
ric cardiac surgery, especially with regards to previous
colonization with ESBLs. No data is available for ESBL
colonization and/or infection in children with congenital
heart disease in Morocco.
In our country, some studies showed that the occur-
rence of ESBLs was high on faecal carriage (42.8%) [17],
28.6% in blood culture, superficial and deep pus [18] and
catheters and 20.7% in blood cultures, urine, pus and
bronchial sampling [19].
Multidrug-resistant bacteria (MDRB) screening is rec-
ommended as a standard protocol for all cardiac surgery
patients [20]. Kim et al. [21] suggest that in a non-
epidemic situation, systematic detection of ESBLs in
ICU patients is not cost-effective, and that stringent
contact precaution for infected patients might be ad-
equate. However, our institution applies selection criteria
based on previous hospitalization or prior use of antibi-
otics to perform MDRB screening. Screening of all
MDRBs, including MRSA and carbapenemases, was per-
formed for all patients with a risk criterion. In this study,
we only reported ESBL-E screening because no MRSA
strain was isolated and only one strain of Klebsiella
pneumoniae was both carbapenemases- and ESBL-
producing. Therefore, it appears more relevant to focus
on ESBLs.
We found 15% ESBL colonization, similar to a Polish
study on the same population (16% MDRB) [20] and to
a reported colonization rate in a 2012 report from
France (15%) [22]. However, it was lower than those re-
ported by Kim et al. in a Korean study of intensive care
unit patients (28.2%) [21]; in another recent Korean
study, the authors reported a rate of 42.5% in ICU pa-
tients and 20.3% even in healthy persons [23].
The majority of ESBL strains in this study were iso-
lated from anal swab. This finding is similar to those re-
ported in colonization screening by other authors [20].
It could be interesting to discuss whether screening for
MDRB in our setting should be done only with anal
swab (just one site of sampling), with the objective of
enhancing the cost-effectiveness of MDRB screening.
The most common isolated species were Klebsiella
pneumoniae in our study, while others reported higher
frequencies of Escherichia coli isolation [20].
Otherwise, nosocomial infections in children after
heart surgery occur in 12.9% to 30.8% of cases [24, 25].
Bloodstream infections (BSI) are one of the most
Fig. 1 Description of the study design and results. (Legend: NI:
Nosocomial Infection. NNI: No Nosocomial Infection)
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common infections [26–28] seen in children undergoing
cardiac surgery, with studies reporting incidence as high
as 65% of total nosocomial infections [25].
The most common organisms detected in infectious
endocarditis after surgery for congenital heart defect
were Streptococcus viridans and Staphylococcus aureus
(each 23% of total), as reported by Cynthia et al. [29].
However, other studies have reported that Gram-
negative bacilli (GNB) were the most frequent isolates in
nosocomial pneumonia (NP) in infants in a paediatric
surgical ICU after cardiac surgery (86.1%) [30]. The
main GNB were Acinetobacter baumannii isolates
(13.9%), Pseudomonas aeruginosa (10 isolates, 12.7%),
Klebsiella pneumoniae (7 isolates, 8.9%), and E. coli
(6 isolates, 7.6%). The bacteria-producing extended
spectrum beta-lactamases were mainly K. pneumoniae
and Escherichia coli [30].
In our study, infection with ESBLs was found in
five patients, four of them likely infected with a strain
of the same species isolated upon colonization screen-
ing at admission, with the same antibiotic susceptibil-
ity features. We could not confirm the clonality of
colonization and infection isolates with molecular
study due to lack of resources. Only one case was in-
fected with E. coli after being colonized by K.
pneumoniae. This case was probably a nosocomial in-
fection contracted during hospitalization in the ICU.
We could not confirm this due to a lack of tech-
niques and reagents. In addition, the conventional
technique used for the detection of ESBL-E is not
very sensitive; possible colonization by E. coli could
not be identified with this technique. On the other
hand, since this case was a newborn, a possible car-
riage in the mother could be at the origin of this
contamination with E. coli.
Carriers of ESBLs appear to be at higher risk of subse-
quent bacteraemia compared with non-carriers [31].
Due to the spread of extended-spectrum β-lactamase-
producing E. coli (ESBL-EC) carriage, a practitioner may
be tempted to modify empirical antibiotic therapy in
known carriers with signs of infection.
Our results, even with a lower rate (23%), demonstrate
that previous colonization with ESBLs may be a risk fac-
tor for the occurrence of infections after cardiac surgery
in paediatric patients. In fact, the difference in the
incidence of those infections between the two groups
(colonized and non-colonized) was significant.
So, should we prescribe antibiotic prophylaxis system-
atically on previously colonized children undergoing
cardiac surgery?
Table 1 ESBLs isolated in colonized patients who had post-operative ESBL infection
Patient Colonization Colonization bacteria Site of Colonization Infection bacteria Site of infection Type of surgery
1 Positive E. coli Nasal E. coli Blood Aortic coarctation
2 Positive KP Nasal E. coli Pus/Wound Isolated ventricular
septal defect
3 Positive KP Anus K.P Pulmonary Pulmonary atresia
4 Positive E. coli Anus E. coli Urinary Tetralogy of Fallot
E. coli Escherichia coli, KP Klebsiella pneumonia, EC Enterobacter cloacae
Table 2 ESBLs isolated in colonized patients who did not have post-operative ESBLs infection
Patient Colonization Colonization bacteria Site of Colonization Type of surgery
1 Positive KP Anus Pulmonary atresia
2 Positive E. coli Nasal Atrioventricular septal defects
3 Positive E. coli Anus Atrioventricular septal defects
4 Positive KP Anus/Throat Atrioventricular septal defects
5 Positive E. coli Urinary tract Pulmonary artery banding
6 Positive EC Anus Pulmonary artery banding
7 Positive EC Anus Isolated ventricular septal defect
8 Positive KP Nasal/Anus Isolated ventricular septal defect
9 Positive KP Nasal Isolated ventricular septal defect
10 Positive KP Anus Aortic coarctation
11 Positive KP Anus Aortic coarctation
12 Positive KP Throat Aortic coarctation
13 Positive E. coli Nasal/Anus Complete transposition
E-coli Escherichia coli, KP Klebsiella pneumonia, EC Enterobacter cloacae
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Actually, antibiotic prophylaxis for cardiac surgery
is a controversial area. Recent systematic reviews and
meta-analyses of randomized controlled trials have
concluded that surgical site infection can be reduced
by prolonging prophylaxis for 24–48 h. In addition,
post-operative pneumonia and every cause of mortal-
ity can be reduced by giving agents with both anti-
Gram-negative and anti-Gram-positive activity [32].
The choice of the most appropriate regimen remains
open to debate, and yet no recommendations exist
for paediatric cardiac surgery patients.
Our goal was to gain an insight into occurrence
rate of colonization and infection with ESBLs in this
specific population. Our findings were very concern-
ing, and may influence our screening and antibiotic
prophylaxis policies.
It is clear that infection control for ESBL-producing
strains would be achieved through active surveillance of
high-risk patients, such as those in the ICU [33]. Some
authors claim that strict contact precautions might be
more appropriate and cost-effective than systematic
MDRB screening. Nevertheless, ESBL colonization
rate in paediatric cardiac surgery patients is still rela-
tively low, allowing the prevention of infection
through systematic screening. This screening will pro-
vide epidemiological data to guide antibiotic therapy
policies. It must be applied for all MDRBs, even if
ESBLs are the most common.
In fact, besides ESBLs, carbapenemase-producing
Enterobacteriaceae seem to be of great concern in our
geographic area. Their recent emergence and the poten-
tial for horizontal transfer of resistance genes make crit-
ical the control of their spread while the frequencies are
still low [21]. This will require rapid and accurate testing
of carbapenem-resistant isolates from clinical specimens,
as well as the adoption of appropriate infection control
procedures if carbapenemase-producing isolates are
found. In addition, the incidence of CRE should be mon-
itored continuously. If CRE incidence increases, more
aggressive management, such as active surveillance of
high-risk patients, will be necessary [21].
Our study has many limits. Due to the retrospective
design, we could not have all clinical data that would be
of interest with regard to colonization and infection with
ESBLs, such as hospitalization duration before surgery,
mortality, detailed antibiotic regimen before and after
surgery, and other infections apart from ESBL infections.
Conclusions
Our study demonstrated that the positive carriage of
ESBLs is a risk factor for post-operative infection in
paediatric cardiac surgery patients. The screening for
these bacteria allows the isolation of patients and the
prevention of possible cross-contamination between
highly at-risk patients such as our study population.
Significant progress in the field of hospitalization condi-
tions, hygiene and hand washing will help us to reduce
significantly the prevalence of ESBL transmission and
post-operative infection in our context.
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